ArticleOncotarget2018

Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL.

Morichika Takita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.